Ginkgo Bioworks

© Ginkgo Bioworks

Company News

Ginkgo Bioworks to Take “Decisive Action” Following Disappointing Q1 Financial Results

US-based synthetic biology company Ginkgo Bioworks has published its financial results for Q1 2024. Due to lower-than-expected revenues, Ginkgo has announced several initiatives to accelerate its path to operational breakeven by the end of 2026. The company’s total Q1 revenue was $38 million, down from $81 million in the comparable prior year period. This was predominantly driven by the ramp-down of Covid-19 testing in schools. Cell engineering revenue decreased by 18% to $28 million due to a decline in revenue from early-stage customers, partially offset by growth from large customers. Biosecurity revenue was $10 million, with a gross profit margin of 8%. Q1 loss from operations was $(178) million, compared to $(216) million in the same period last year; stock-based compensation expenses were reduced from …


Crepes filled with animal-free cream

© Imagindairy


Imagindairy and Ginkgo Bioworks Receive Grant to Accelerate the Launch of Cow-Free Dairy Proteins

Israeli animal-free dairy protein developer Imagindairy and Ginkgo Bioworks (NYSE: DNA), a Boston-based biotech specializing in cell programming, announce a partnership to accelerate the introduction of a new wave of cow-free dairy. A joint grant from the Board of Governors of the Israel-US Binational Industrial Research and Development (BIRD) Foundation has partly funded the companies’s multiyear program to commercialize non-whey proteins. The collaboration will leverage Ginkgo Bioworks’ Protein Expression Services and Imagindairy’s process development and scale-up expertise to develop and manufacture animal-free whey cost-effectively to reach prices similar to dairy proteins.  Ginkgo is also working with the Chicago-based alt-seafood producer Aqua Cultured Foods to improve the economics and functions of its microbial strains for large-scale operations. Jennifer Wipf, CEO at Ginkgo Bioworks, shares, “Being awarded this …



© Phytolon


Ginkgo Bioworks and Phytolon Partnership Unlocks Full Yellow-to-Purple Spectrum in Natural Food Colors

Ginkgo Bioworks and Phytolon have announced the successful completion of the first development milestone in their partnership, unlocking the full color palette of the yellow-to-purple spectrum accessible for Phytolon’s natural food colors. Phytolon’s natural betalain pigments, derived from foods like beets and cactus fruit, present a safe and sustainable alternative to synthetic dyes. With heightened scrutiny and bans on synthetic dyes, this new innovation aims to address growing regulatory concerns and consumer demand for nature-derived products. After being founded in 2018, Phytolon secured $4.1 million in 2020 to bring its fermented food colors to market, focusing on product development and refining its fermentation technology. The company has been actively seeking partnerships ever since to enhance its technology and expand its market reach. The partnership with …


Vivici fermentation unit

© Vivici


Vivici Partners with Ginkgo Bioworks to Expand Portfolio of Sustainable Dairy Proteins

Vivici, a Dutch B2B ingredients startup utilizing precision fermentation, and Ginkgo Bioworks, a cell programming and biosecurity platform, have announced a strategic partnership to advance the production of sustainable animal-free dairy proteins. Focusing on meeting the increasing global demand for sustainable and appealing proteins, Vivici utilizes precision fermentation techniques to create animal-free dairy proteins with microorganisms. Ginkgo Bioworks is set to enhance the partnership with its protein production services and generative AI platform. The company’s strategic role involves creating a comprehensive library, where it will screen and cultivate top-performing strains and then deliver them to Vivici for final evaluation. Stephan van Sint Fiet, CEO at Vivici, commented, “We are thrilled to collaborate with Ginkgo. Ginkgo’s scale and AI-driven approach to designing strains for protein expression …


QL AG animal-free dairy



QL AG Partners with Ginkgo Bioworks to Develop Fermentation-Based Dairy Proteins

Swiss-based QL AG, a food technology firm with a mission to “feed the world, skip the cow, and reduce greenhouse gas emissions,” has unveiled a strategic partnership with Ginkgo Bioworks, a cell programming and biotech company, to introduce fermentation-based dairy proteins that are on par with traditional options in terms of nutritional value. QL AG, known for its innovative biotechnological solutions, seeks to leverage Ginkgo Bioworks’ proficiency in strain engineering of microorganisms to develop animal-free dairy proteins to cater to evolving consumer demands. Kalpesh Parekh, vice president of business development at Ginkgo Bioworks, cited the vast potential of dairy proteins for the company’s platform: “Dairy proteins provide an exciting opportunity to leverage our platform, as they have traditionally presented product developers with significant challenges around …


A bowl of mycoprotien meatballs

© Nosh Biofoods

Fungi, Mushrooms & Mycelium

Nosh Biofoods and Ginkgo Bioworks Partner to Create “Superior” Mycoprotein for Red Meat Alternatives

Berlin-based startup Nosh Biofoods and biotech company Ginkgo Bioworks (NYSE: DNA) announce a new partnership to produce what they claim would be a superior mycoprotein ingredient for red meat alternatives to make them “taste closer to real meat than ever before.” Creating plant-based red meat, free from binders and chemical additives, continues to challenge the industry. Still, these two companies are poised to solve this problem and develop a mycoprotein with better taste, color, performance, and nutrition for clean-label alternatives. As part of the collaboration, Nosh Biofoods will leverage Ginkgo Bioworks’ capacity to discover and deliver protein-producing fungi strains with superior sensorial profiles to provide the rich taste, juiciness, and color of red meat in NPDs.  “ is eager to enable the transition from animal-based to animal-free products. What …


cacao fruit

© nutt-

Investments & Finance

Boston’s Ayana Bio Pledges $3M to Accelerate Cacao Bioactives Through Plant Cell Tech

Boston-based Ayana Bio, a spinoff from Ginkgo Bioworks, has announced a $3 million investment to accelerate the production of cacao bioactives using plant cell technology to make consumer products for markets such as health and wellness, F&B, and cosmetics. Ayana Bio will utilize the capital to expedite commercialization of its cacao ingredients and prioritize R&D of the benefits of different cacao varieties as well as possible usages and applications to expand partnerships with CPG companies. Producing high polyphenol cacao extracts  Ayana Bio leverages plant cell technology —growing plant cell lines in bioreactors rather than agricultural production — to discover and produce plant and fungal bioactives that support and improve human health. According to the biotech, cacao contains biologically active compounds that support healthy digestion, cardiovascular health, cognition, …